Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Sovaldi
Sovaldi
Gilead Sciences: Here Comes the Competition
Barron's
Tue, 10/7/14 - 01:21 pm
Gilead Sciences
hepatitis C
Sovaldi
Merck
AbbVie
Idenix
Bristol-Myers Squibb
Achillion
Sovaldi may be cost-effective, but the U.K. can't afford it, documents say
Fierce Pharma
Tue, 10/7/14 - 08:09 am
Sovaldi
UK
drug pricing
Gilead Sciences
hepatitis C
Gilead Outperforms Biotech Sector Over Success Of Sovaldi, Harvoni, And Zydelig
Bidness Etc.
Mon, 10/6/14 - 07:42 am
Gilead Sciences
Sovaldi
Harvoni
Zydelig
Can Gilead Sciences Be A Do-Gooder And Still Do Well?
Investor's.com
Sat, 09/27/14 - 09:23 am
Gilead Sciences
Sovaldi
Gilead’s Hepatitis C Combination Wins EU Agency Backing
Bloomberg
Fri, 09/26/14 - 09:02 am
Gilead Sciences
hepatitis C
Europe
Sovaldi
ledipasvir
Generic Sovaldi makers could pocket upwards of $600m says analyst
In-Pharma Technologist
Thu, 09/25/14 - 09:25 am
generics
Sovaldi
Gilead Sciences
hepatitis C
Mylan
Strides Arcolab
Cadila
Cipla
Hetero Labs
Ranbaxy
Sequent Scientific
Dropout rate on $1,000-a-day pill jumps during transition to ‘real world’
Marketwatch
Wed, 09/17/14 - 04:32 pm
Gilead Sciences
Sovaldi
drug pricing
hepatitis C
Gilead Deal to Sell Sovaldi in Poor Countries Meets Criticism
WSJ Pharmalot
Mon, 09/15/14 - 07:21 pm
Gilead Sciences
drug pricing
hepatitis C
Sovaldi
U.S. Hepatitis Problem to Continue Driving These 4 Top Stocks
24/7 Wall St
Mon, 09/15/14 - 11:36 am
hepatitis C
Gilead Sciences
AbbVie
Achillion
Merck
Sovaldi
Idenix
Gilead signs pact with 7 firms for cheap copies of hepatitis C drug
Yahoo/Reuters
Mon, 09/15/14 - 08:49 am
Gilead Sciences
Sovaldi
generics
hepatitis C
Cipla
Ranbaxy
Cadila
Mylan Labs
Strides Arcolab
Hetero Drugs
Sequent Scientific
Gilead to raise price for new hepatitis C drug above $84,000
Yahoo/Reuters
Fri, 09/12/14 - 07:10 pm
Gilead
Sovaldi
drug pricing
hepatitis C
Gilead Sciences: Sovaldi Sales Slip But Less Than Feared
Barron's
Fri, 09/12/14 - 06:58 pm
Gilead Sciences
Sovaldi
hepatitis C
Can anything slow Gilead down? Analysts say no
CNBC
Mon, 09/8/14 - 08:16 pm
Gilead Sciences
Sovaldi
hepatitis C
Cheaper Version Of Gilead's Sovaldi Might Be On The Cards
Bidness Etc.
Fri, 09/5/14 - 08:05 am
Gilead Sciences
Sovaldi
hepatitis C
Gilead Close to Sending $84,000 Drug to Poor Countries
Bloomberg
Thu, 09/4/14 - 06:30 pm
Gilead Sciences
Sovaldi
hepatitis C
Has Gilead Sciences, Inc.'s Star Drug Already Peaked?
Motley Fool
Fri, 08/29/14 - 08:10 am
Gilead Sciences
Sovaldi
hepatitis C
Bristol-Myers gets the approval Gilead didn't want: Daklinza + Sovaldi for hep C
Fierce Pharma Marketing
Wed, 08/27/14 - 10:19 am
Bristol-Myers Squibb
Gilead Sciences
hepatitis C
Daklinza
Sovaldi
Gilead (GILD) Hits 52-Week High Thanks to Sovaldi
Yahoo/Zacks.com
Thu, 08/21/14 - 09:43 am
Gilead Sciences
Sovaldi
hepatitis C
Most Popular News Headlines For Friday/Saturday August 15-16 2014
CP Wire
Mon, 08/18/14 - 11:48 am
Pfizer
FDA
Eisai
Amgen
Gilead
Sovaldi
Roche
DEA
Repligen
drug manufacturing
Most popular news headlines for Friday/Saturday August 15-16 2014
Mon, 08/18/14 - 11:47 am
Pfizer
FDA
Eisai
Amgen
Gilead
Sovaldi
Roche
DEA
Repligen
drug manufacturing
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »